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0 Apparent caspase independence 
of programmed cell death in 
Dictyostelium. 
RA Olie, F Durrieu, S Cornillon, 
G Loughran, J Gross, WC Earnshaw 
and P Golstein (1998). Curr. Biol. 8, 
955-958. 
During normal development, cell 
elimination occurs by programmed cell 
death (PCD); the best known type of 
PCD is apoptosis. Activation of cysteine 
proteases termed caspases is required in 
many instances of animal PCD, but its 
role outside the animal kingdom is, as 
yet, unknown. PCD occurs during 
developmental stages in the slime mold 
Dictyostehm discoia’eum. Under favorable 
conditions, Dictyostdium multiplies as a 
unicellular organism. Upon starvation, a 
pathway involving aggregation, 
differentiation and morphogenesis 
induces the formation of a multicellular 
fungus-like structure, consisting mainly 
of spores and stalk cells, the latter being 
a result of cell death. The authors 
examined whether caspase activity is 
required for Dictyostelium cell death. 
They found that caspase inhibitors, such 
as DEVD- fmk. did not affect cell 
death, although some caspase inhibitors 
that did not inhibit cell death impaired 
other stages in development and could 
block affinity labelling of soluble 
extracts of Dictyostehn cells with an 
activated caspase-specific reagent. The 
simplest interpretation of these results 
is that in Dictyostehm, whether or not 
caspase-like molecules exist and are 
required for some developmental steps, 
caspase activation is not required for cell 
death itself. 
17 August 1998, Brief Communication, 
Current Biology. 
0 Essential requirement for 
caspase-I/FLICE in the 
initiation of the Fas-induced 
apoptotic cascade. 
Peter Juo, Calvin J Kuo, Junying 
Yuann and John Bleniss (1998). 
Curr. Biol. 8, 1001-l 008. 
Fas (APO-l/CD95), a member of the 
tumor necrosis factor receptor (TNF-R) 
family, induces apoptosis when 
cross-linked with either Fas ligand or 
agonistic antibody (Fas antibody). The 
Fas-Fas ligand system has an important 
role in the immune system where it is 
involved in the downregulation of 
immune responses and the deletion of 
peripheral autoreactive T lymphocytes. 
The intracellular domain of Fas 
interacts with several proteins, including 
FADD (MORT-l), and the adaptor 
protein FADD can, in turn, interact with 
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the cysteine protease caspase-8. As 
caspase-8 is recruited to the Fas 
complex through FADD and can 
autoactivate upon oligomerization, 
caspase-8 could, potentially, initiate the 
caspase cascade. In a genetic screen for 
essential components of the Fas- 
mediated apoptotic cascade, the authors 
isolated a Jurkat T lymphocyte cell line 
deficient in caspase-8 that was 
completely resistant to Fas-induced 
apoptosis. Complementation of this cell 
line with wild-type caspase-8 restored 
Fas-mediated apoptosis. Fas activation 
of multiple caspases and of the stress 
kinases ~38 and c-Jun NH2-terminal 
kinase (JNK) was completely blocked in 
the caspase-8-deficient cell line. The 
cell line was severely deficient in cell 
death induced by TNF-a This study 
provides the first generic evidence chat 
caspase-8 is essential in the Fas 
signaling pathway and suggests that 
caspase-8 might participate in multiple 
apoptotic pathways. 
26 August 1998, Research Paper, 
Current Biology. 
0 A new large proteolytic complex 
distinct from the proteasome is 
present in the cytosol of fission 
yeast. 
Pawel A Osmulski and Maria 
Gaczynskas (1998). Cur. Biol. 8, 
1023-l 026. 
The proteasome, a eukaryotic 
proteolytic complex, is classed as the 
major nonlysosomal protease by its 
known and suspected functions, its size 
and its complexity. It seems improbable 
that other enzymes could be capable of 
substituting, even partially, for the 
potent proteasome, as this complex has 
a vital role in many cellular processes. It 
is possible, however, to adapt cultured 
EL-4 mouse lymphoma cells to survive 
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in the presence of a specific inhibitor of 
the proteasome. The inhibition of the 
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proteasome in these adapted EL-4 cells 
is accompanied by a dramatic increase in 
the activity of a new, as yet 
uncharacterized, large proteolytic 
complex. Here, the authors have 
presented evidence that a similar 
proteolytic activity is constitutively 
present in fission yeast. 
~Sc~i~osuccliclro7PryrrspombP, and that the 
yeast and mouse enzymes share basic 
ph~sicochemi~l properties. The 
anchors have shown that the S. pornijt 
protease is found in two stable 
oligomeric forms, both of which are 
peptidases, although only the larger 
form acts as a proteinase. The arrthors 
refer to the new proteolytic complex as 
the multicorn to indicate its analogy to 
the archaebacteriai tricorn protease. 
31 August 1998, Brief Communication, 
Current Biology. 
I7 The protein tyrosine 
phosphatase SHP-1 regulates 
integrin-mediated adhesion of 
macrophages. 
Tamara IA Roach, Suzanne E Slater, 
Lynn S White, Xiaoling Zhang, Philip, 
W Majeros, Eric J Brown and 
Matthew L Thomas (1998). Curr. 
Biol. 8, 1035-l 038. 
The Src homology 2 domain 
phosphatase-1 (SHP-1) is a tvrosine 
phosphatase containing two amino- 
terminal SH2 domains that is expressed 
primarily bv hematopoietic-derived 
cells. ‘I‘he viable motheaten (Hr/#FrP-i.) 
mutant mice (mu;) suffer from 
progressive inflammation dnc to a 
deficiency of SHP-I enzyme activity 
and die at 33 months of age from 
macrophagc and neutrophil 
accumulation in the lung. ‘I’he 
mechanism by which SHP-1 deficiency 
leads to inflammation is unknown. The 
anthers found that macrophages from 
~?JF mice adhered and spread to a 
greater extent than normal macrophages 
through crmfi2 integrin-mediated 
contacts. hlacrophages deficient in the 
transmeinb~~lle tyrosine phosphatase 
(:D4S (GN%--1 spontaneo~Isl~ 
detached from am/32 integrin contacts, 
whereas cells deficient in both CD45 
and SHfJ-1 did not. f n SHP-1 -deficient 
macropha.gcs there was a IO-15-f& 
increase in D-3 phospholipid products 
of phospl~atid~linositol (PI) 3-kinase. 
~~oncomitantl~, there was a Z-j-fold 
increase in membrane-associated I’I 
3-kinase activity in mev macrophages 
relative to normal macrophagcs. 
‘lieatment ofmacrophages with the 
PI 3-kinase inhibitors wortmannin or 
LY294002 resulted in a dramatic 
detachment of cells, indicating that 
PI 3-kinase activity is reclnired for 
adhesion. These data demonstrate that 
SHP-I is necessary for detachment from 
am&? i~te~rin-mediated contacts in 
primary macrophages and strggest that a 
defect in this pathway could contribute 
to inflammatory disease. 
31 August 1998, Research Paper, 
Current Biology. 
fl The crystal structure of human 
cytosolic serine 
hydroxymethyltransferase: a 
target for cancer chemotherapy. 
Suzanne B Renwick, Keith Snetl and 
Ulrich Baumann (1998). Structure 6, 
1105-1116. 
Serine hvdroxymethyltransferase 
(SHiVI) is a ubiquitous enzyme found 
in all prokarvotes and enkaryotes. As an 
enzyme of the thymidylate svnthase 
metabolic cycle, SHM’I‘ catalyses the 
retro-aldol cleavage of serine to glvcinc, 
with the resulting hydroxvmethyl group 
being transferred to tetrahydrofolatc to 
form 5.1 0-methylenc-retrah?‘drt,titlatc. 
‘l’he latter compound the major sonrcc of 
one-carbon units in metabolism. 
Elevated SIIhI’f’ activ:ity has been shown 
to be coupled to the increased demand 
for DNA synthesis in rapidly 
proliferating cells, particularly tumonr 
cells. Consequenrlv. the central role of 
SHh17’ in nuclrotide biosynthesis makes 
it an attractive target for cancer 
chemotherapy. ‘l‘he authors hav-c sohcd 
the crystal strncttnc of h~~rnan cytosolic 
SHhIT by mnltiplc isomorphons 
r eplacemcnt. ‘l‘hc monomer has a fold 
typical for a class pyridoxal 
S’-phosphate (I’I,f’)-~leI)cnd~nt 
enzymes. ‘l‘he tctramer association i\ 
best described as a ‘dimcr of dimcrs’ 
where residues from both subunits of 
one ‘tight’ dimcr contribtrtc to the 
active site. \Ianv ofrhe results ofsitc- 
directed mntagcnesis studies can easil! 
be rationalisctl or rc-interpreted in light 
of the strnctnre prcscntcd here. ‘l‘he 
strncture will atso bc of tisc for the 
rational design of inhibitors that wulcl 
he useful in anricanccr thertlpy. 
15 September 1998, Research Paper, 
Structure. 
71 Structural basis of inhibitor 
selectivity in MAP kinases. 
Zhulun Wang, Bertram J 
Canagarajah, Jeffrey C Boehm, 
Skouki KassisB, Melanie H Cobb, 
Peter R Young, Sherin Abdel- 
Meguid, Jerry L Adams and 
Elizabeth J Goldsmith (1998). 
Structure 6, 1 1 17-l 128. 
The mitogcn-acci\atcd protein (\lAI’) 
kinases arc important signaling 
molecrrlcs that participate in diverse 
cellular tvents. ‘l‘hev arc potential 
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targets for intervention in inflammation, 
cancer, and other diseases. The MAP 
kinase p38 is responsive to 
environmental stresses and is involved in 
the production of cytokines during 
inflammation. In contrast, the activation 
of the MAP kinase ERKZ (extracellular- 
signal-regulated kinase 2) leads to 
cellular differentiation or proliferation. 
. 
The anti-inflammatory agent 
pyridinylimidazole and its analogs (SB 
compounds) are highly potent and 
selective inhibitors of ~38, but not of the 
closely-related ERK’Z, or other 
serine/threonine kinases. Although these 
compounds are known to bind to the 
ATP-binding site, the origin of the 
inhibitory specificity towards p38 is not 
clear. The authors report the structural 
basis for the exceptional selectivity of 
these SB compounds for p38 over 
ERKZ, as determined by comparative 
crystallography. The crystal structures of 
four SB compounds in complex with p38 
and of one SB compound and 
olomoucine, a better inhibitor of ERKZ, 
in complex with ERKZ are presented 
here. The SB inhibitors bind in an 
extended pocket in the active site and 
are complementary to the open domain 
structure of the low-activity form of ~38. 
The relatively closed domain structure 
of ERK’Z is able to accommodate the 
smaller olomoucine. The unique 
kinase-inhibitor interactions observed in 
these complexes originate from amino- 
acid replacements in the active site and 
replacements distant from the active site 
that affect the size of the domain 
interface. This structural information 
should facilitate the design of better 
MAP-kinase inhibitors for the treatment 
of inflammation and other diseases. 
15 September 1998, Research Paper, 
Structure. 
0 Mass spectrometric and 
thermodynamic studies reveal 
the role of water molecules in 
complexes formed between SH2 
domains and tyrosyl 
phosphopeptides. 
Evonne Chung, Denise Henriques, 
Debora Renzoni, Marketa Zvelebil, 
J Michael Bradshaw, Gabriel 
Waksman, Carol V Robinson and 
John E Ladbury (1998). Structure 6, 
1141-115. 
SHZ domains have a fundamental role 
in signal transduction. These domains 
interact with proteins containing 
phosphorylated tyrosine residues and, in 
doing so, mediate the interactions of 
proteins involved in tyrosine kinase 
signalling. The issue of specificity in 
SHZ domain interactions is therefore of 
great interest in terms of understanding 
tyrosine kinase signal-transduction 
pathways and in the discovery of drugs 
to inhibit them. Water molecules are 
found at the interfaces of many 
1 
complexes, but, to date, little attention 
has been paid to their role in dictating 
specificity. The authors used a 
combination of nanoflow electrospray 
ionization mass spectrometry (ESI-MS), 
isothermal titration calorimetry and 
structural data to investigate the effect 
of water molecules in complexes formed 
between the SHZ domain of tyrosine 
kinase Src and tyrosyl phosphopeptides. 
Binding studies have been performed 
using a series of different peptides that 
were selected to allow changes in the 
water content at the complex interface 
and demonstrate changes in specificity. 
ESI-MS enables quantification of the 
number of water molecules that interact 
with a higher affinity than those 
generally found solvating the 
biomolecular complex. Comparing the 
interactions of different peptides, the 
authors show that an intricate network 
of water molecules have a key role in 
dictating specificity. The use of mass 
spectrometry to quantify tightly bound 
water molecules may prove of general 
use in structural biology, where an 
independent determination of the water 
molecules associated with a structure 
would be advantageous. Furthermore, 
the ability to assess whether given water 
molecules are important in high-affinity 
binding could make this method a 
precious tool in drug design. 
15 September 1998, Research Paper, 
Structure. 
0 VEGF and the Fab fragment of a 
humanized neutralizing 
antibody: crystal structure of the 
complex at 2.4 A resolution and 
mutational analysis of the 
interface. 
Yves A Muller, Yvonne Chen, Hans 
W Christinger, Bing Li, Brian C 
Cunningham, Henry B Lowman and 
Abraham M de Vos (1998). 
Structure 6, 1153-l 167. 
Vascular endothelial growth factor 
(VEGF) is a highly specific angiogenic 
growth factor; anti-angiogenic treatment 
through inhibition of receptor activation 
by VEGF might have important 
therapeutic applications in diseases such 
as diabetic retinopathy and cancer. A 
neutralizing anti-VEGF antibody shown 
to suppress tumor growth in an in vivo 
murine model has been used as the 
basis for production of a humanized 
version. The authors present the crystal 
structure of the complex between 
VEGF and the Fab fragment of this 
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humanized antibody, as well as a 
comprehensive alanine-scanning 
analysis of the contact residues on both 
sides of the interface. Although the 
VEGF residues critical for antibody 
binding are distinct from those 
important for high-affinity receptor 
binding, they occupy a common region 
on VEGF, demonstrating that the 
neutralizing effect of antibody binding 
results from steric blocking of 
VEGF-receptor interactions. The 
findings suggest that the character of 
antigen-antibody interfaces is similar to 
that of other protein-protein interfaces, 
such as ligand-receptor interactions; in 
/ I 
the case of VEGF, the principal 
difference is that the residues essential 
for binding to the Fab* fragment are 
concentrated in one continuous segment 
of polypeptide chain, whereas ihose 
essential for binding to the receptor are 
distributed over four different segments 
and span across the dimer interface. 
15 September 1998, Research Paper, 
Sfructure. 
0 The crystal structure of the 
novel snake venom 
plasminogen activator TSV-PA: 
a prototype structure for snake 
venom serine proteinases. 
Marina AA Parry, Uwe Jacob, Robert 
Huber, Anne Wisner, Cassian Bon 
and Wolfram Bode (1998). 
Structure 6, 1195-l 206. 
Tnimere.sums stejnqbi venom 
plasminogen activator (TSV-PA) is a 
snake venom serine proteinase that 
specifically activates plasminogen. 
Snake venom serine proteinases form a 
subfamily of trypsin-like proteinases that 
are characterised by a high substrate 
specificity and resistance to inhibition. 
Many of these venom enzymes 
specifically interfere with haemostatic 
mechanisms and have a long-circulating 
half-life. For these reasons, several of 
them have commercial applications and 
are potentially attractive pharmacological 
tools. The determination of the crystal 
structure of TSV-PA reveals unique 
structural elements such as the presence 
of a phenylalanine at position 193. a 
carboxy-terminal tail clamped \ia a 
disulphide bridge to the 99 loop, and a 
structurally conserved Asp97 residue. 
The presence of a ris proline at position 
218 is in agreement with evolutionary 
relationships to glandular kallikrein. The 
authors postulate that Phel93 accounts 
for the high substrate specificity of 
TN-PA, rendering it incapable of 
forming a stable complex with bovine 
pancreatic trypsin inhibitor and other 
extended substrates and inhibitors. The 
three-dimensional structure presented 
here is the first of a snake I enom serine 
proteinase and provides an excellent 
template for modelling other 
homologous family members. 
15 September 1998, Research Paper, 
Structure. 
